4.4 Article

Alcohol-associated liver disease: Epidemiology and management

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection

Concepcion Gomez-Medina et al.

Summary: Alcohol-related liver disease (ALD) encompasses a wide range of clinical presentations, from asymptomatic patients to severe complications like cirrhosis and cancer. Late-stage identification of ALD limits effective treatment options, highlighting the need for early detection, which is lacking in many countries. Alcohol underreporting by patients hampers the identification of alcohol misuse, but there are biomarkers and non-invasive techniques available to detect recent alcohol use and assess fibrosis severity. This article provides a comprehensive overview of the differences between early stages of ALD and alcohol-induced hepatitis (AH) and suggests campaigns targeting early identification of subclinical forms to prevent life-threatening complications. (Clin Mol Hepatol 2023;29:1-15)

CLINICAL AND MOLECULAR HEPATOLOGY (2023)

Article Medicine, General & Internal

Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis A Randomized Clinical Trial

Alexandre Louvet et al.

Summary: This study aimed to determine the efficacy of amoxicillin-clavulanate compared with placebo on mortality in patients hospitalized with severe alcohol-related hepatitis and treated with prednisolone. The results showed that amoxicillin-clavulanate combined with prednisolone did not improve 2-month survival compared with prednisolone alone. Therefore, prophylactic antibiotics may not be beneficial for improving survival in patients hospitalized with severe alcohol-related hepatitis.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Gastroenterology & Hepatology

Global burden of liver disease: 2023 update

Harshad Devarbhavi et al.

Summary: Liver disease causes two million deaths annually, accounting for 4% of all deaths worldwide, with a higher prevalence among men. The main causes of death are complications of cirrhosis and hepatocellular carcinoma, while acute hepatitis contributes to a smaller proportion. The major factors leading to cirrhosis globally are viral hepatitis, alcohol consumption, and non-alcoholic fatty liver disease. Drug-induced liver injury is also becoming a significant cause of acute hepatitis. This updated version of the global burden of liver disease focuses on new information related to alcohol-associated liver disease, non-alcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma. Moreover, it gives attention to liver disease burden in the often overlooked region of Africa.

JOURNAL OF HEPATOLOGY (2023)

Review Gastroenterology & Hepatology

Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors

Daniel Q. Huang et al.

Summary: Global alcohol consumption has increased, leading to a rise in the incidence of alcohol-associated cirrhosis and hepatocellular carcinoma. Heavy alcohol consumption is a major cause of morbidity and mortality. Measures are needed to reduce the burden of alcohol-related liver diseases.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Review Gastroenterology & Hepatology

Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease

Maria Hernandez-Tejero et al.

Summary: Alcohol-related liver disease (ALD) is a leading cause of chronic liver disease and liver-related deaths worldwide. It encompasses various disorders and the most severe form is alcohol-associated hepatitis. The amount of alcohol consumed is the most important risk factor for ALD. Prolonged alcohol abstinence is the only effective therapy. Several potential biomarkers have been identified for diagnosis and prognosis in patients with ALD.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis

Anahita Rabiee et al.

Summary: This retrospective cohort study examined the effect of medications for alcohol use disorder (MAUD) on all-cause mortality in patients with alcohol-associated cirrhosis and active alcohol use. The study found that MAUD treatment was associated with improved survival in these patients.

HEPATOLOGY COMMUNICATIONS (2023)

Article Gastroenterology & Hepatology

The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

D. Morales-Arraez et al.

Summary: This study assessed the accuracy of different scoring systems to predict short-term mortality in alcohol-associated hepatitis (AH) and found that the MELD score had the best performance in predicting short-term mortality.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic Hepatitis

Richard Parker et al.

Summary: By analyzing the trajectory of serum bilirubin concentration over the course of hospital admissions, we can predict spontaneous survival and the need for treatment in patients with alcoholic hepatitis.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Review Dermatology

Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta-analysis

Nipun Verma et al.

Summary: Fungal infections have significant implications in cirrhosis, especially in patients with advanced liver disease. There are remarkable geographic variations in the types and sites of fungal infections in cirrhotics globally, with pulmonary infections having the highest prevalence.

MYCOSES (2022)

Review Gastroenterology & Hepatology

Cirrhosis-associated immune dysfunction

Agustin Albillos et al.

Summary: CAID is a spectrum of immune alterations associated with end-stage liver disease, including systemic inflammation and immune deficiency. The severity of CAID progresses parallel with cirrhosis stage, involving low-grade and high-grade systemic inflammatory phenotypes. Therapies targeting modulation of this dysfunctional immune response are currently under evaluation in preclinical and clinical studies.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation

Juan Pablo Arab et al.

Summary: This review discusses the management of alcohol use disorder in patients with alcohol-associated liver disease, particularly in the setting of liver transplantation. It emphasizes the importance of a multidisciplinary approach, including diagnosis, predictors of relapse, behavioral and pharmacological therapies. The review also proposes a comprehensive definition of relapse using contemporary biomarkers to guide future clinical trials for optimizing treatment, transplant selection, and post-transplant care of patients with AUD and cirrhosis.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Letter Gastroenterology & Hepatology

Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic

Sasha Deutsch-Link et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study

Alexandre Louvet et al.

Lancet Gastroenterology & Hepatology (2022)

Review Gastroenterology & Hepatology

Infections in Alcoholic Hepatitis

Bhupinder Kaur et al.

Summary: Severe alcoholic hepatitis (sAH) is defined by certain criteria and is associated with immunocompromised state and increased risk of infections. This review discusses the common infections and risk factors in sAH patients, as well as the diagnostic, therapeutic, and prophylactic strategies currently used.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2022)

Review Medicine, General & Internal

Alcohol-Associated Hepatitis

Ramon Bataller et al.

Summary: This article reviews the epidemiology, pathophysiology, and treatment of alcohol-associated hepatitis, including the evidence for glucocorticoids and liver transplantation.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Review Gastroenterology & Hepatology

Novel Biomarkers of AKI in Cirrhosis

Adria Juanola et al.

Summary: Acute kidney injury (AKI) is a common complication in patients with cirrhosis, which is associated with poor outcomes and decreased survival. The definition of AKI in cirrhosis is currently based on changes in serum creatinine levels. Differential diagnosis is crucial for the appropriate treatment and prognosis as different causes of AKI have different treatment options and prognosis. AKI biomarkers have emerged as a promising tool for differential diagnosis and prognosis in cirrhosis. Particularly, some urine biomarkers, such as neutrophil gelatinase-associated lipocalin (NGAL), have shown potential in daily clinical practice for the differential diagnosis of AKI in cirrhosis. AKI biomarkers may serve as a useful tool for differential diagnosis, prognosis of renal function, and survival in patients with cirrhosis.

SEMINARS IN LIVER DISEASE (2022)

Article Substance Abuse

Alcohol Use Disorder and Alcohol-Associated Liver Disease

Resham Ramkissoon et al.

Summary: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is the world's largest funding agency for alcohol research, supporting a wide range of studies aimed at advancing the diagnosis, prevention, and treatment of alcohol use disorder and related problems. As part of its 50th anniversary celebration, NIAAA organized a two-day symposium to discuss key topics in the field of alcohol research.

ALCOHOL RESEARCH-CURRENT REVIEWS (2022)

Article Gastroenterology & Hepatology

Motivation to Reduce Drinking and Engagement in Alcohol Misuse Treatment in Alcohol-Related Liver Disease: A National Health Survey

Anna Emilie Kann et al.

Summary: This study aimed to identify predictors of motivation to reduce alcohol consumption and whether motivation predicts engagement in alcohol misuse treatment in alcohol-related liver disease (ALD). The results showed that recent hospital admission and severe alcohol problems were associated with motivation to reduce alcohol consumption. Additionally, patients with motivation to reduce alcohol consumption were more likely to engage in misuse treatment.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Review Gastroenterology & Hepatology

Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis

Sahaj Rathi et al.

Summary: Liver cirrhosis is a leading cause of over 2 million deaths annually worldwide, with patients suffering from alcoholic hepatitis and decompensated cirrhosis having dismal short-term survival rates. Liver transplant is the only proven intervention to improve survival, but organ availability is a major limitation. Stem cell therapies, particularly those from bone marrow, show promise in end-stage liver disease patients.

ANNALS OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease

Carolin Lackner et al.

Summary: The SALVE Histopathology Group developed and validated a grading and staging system for alcohol-related liver disease (ALD) and evaluated its prognostic utility in a multinational cohort of 445 patients. The system showed significant associations with disease activity and fibrosis stage, impacting both long-term and short-term outcomes in ALD patients.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population-based study

Elisa Pose et al.

Summary: Alcohol and metabolic syndrome are common cofactors of liver disease. This study found that metabolic syndrome increases the risk of liver fibrosis in individuals with alcohol consumption, especially in high-risk drinkers. Factors such as male gender, liver enzymes, years of consumption, and metabolic syndrome were associated with liver fibrosis in subjects with alcohol consumption.

LIVER INTERNATIONAL (2021)

Article Gastroenterology & Hepatology

A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement

Elisa Pose et al.

Summary: This study found that approximately 9% of patients with alcohol-related decompensated cirrhosis can be delisted due to improvement. Predictors for delisting after improvement include low MELD score, high platelet levels, and higher probabilities for women. Long-term outcomes after delisting are generally favorable.

JOURNAL OF HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Management of bacterial and fungal infections in cirrhosis: The MDRO challenge

Javier Fernandez et al.

Summary: Bacterial infections are common in cirrhotic patients with acute decompensation or acute-on-chronic liver failure, while fungal infections are less common but associated with high short-term mortality. Early diagnosis and appropriate empirical treatment are crucial in managing these patients. Combatting antibiotic resistance and adopting more complex treatment strategies are essential in the current management of cirrhotic patients.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Annalisa Berzigotti et al.

Summary: The article provides the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for assessing liver disease severity and prognosis, with a focus on topics with relevant evidence published in the last 5 years.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study

Juan Pablo Arab et al.

Summary: This international multi-center cohort study found that corticosteroid treatment only improved 30-day survival in patients with severe alcohol-associated hepatitis (AH), particularly those with MELD scores between 25 and 39. There was no survival benefit observed in patients with MELD scores over 51.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

Ditlev Nytoft Rasmussen et al.

Summary: Alcohol is the most common cause of liver-related mortality and morbidity. This study aimed to evaluate and compare the prognostic performance of elastography and blood-based markers in predicting liver-related events, severe infection, and all-cause mortality in patients with a history of excess drinking. The results showed that transient elastography, enhanced liver fibrosis test, and 2D shear-wave elastography are highly accurate prognostic markers in patients with alcohol-related liver disease.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Alcohol Rehabilitation Within 30 Days of Hospital Discharge Is Associated With Reduced Readmission, Relapse, and Death in Patients With Alcoholic Hepatitis

Thoetchai (Bee) Peeraphatdit et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Increasing Burden of Acute-On-Chronic Liver Failure Among Alcohol-Associated Liver Disease in the Young Population in the United States

Ashwani K. Singal et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Agustin Albillos et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide

Neil D. Shah et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Non-invasive diagnosis and biomarkers in alcohol-related liver disease

Christophe Moreno et al.

JOURNAL OF HEPATOLOGY (2019)

Review Substance Abuse

Alcoholic Hepatitis: A Review

Nooshin Hosseini et al.

ALCOHOL AND ALCOHOLISM (2019)

Review Gastroenterology & Hepatology

Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis

Michael Roerecke et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis

A. Sidney Barritt et al.

DIGESTIVE DISEASES AND SCIENCES (2019)

Article Gastroenterology & Hepatology

Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis

Brian P. Lee et al.

GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of alcohol-related liver disease

Mark Thursz et al.

JOURNAL OF HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Grand Rounds: Alcoholic Hepatitis

Ashwani K. Singal et al.

JOURNAL OF HEPATOLOGY (2018)

Review Medicine, General & Internal

Alcohol Use in Patients with Chronic Liver Disease

Daniel Fuster et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Gastroenterology & Hepatology

A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis

Mauricio Garcia-Saenz-de-Sicilia et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study

Richard Parker et al.

JOURNAL OF GASTROENTEROLOGY (2017)

Review Gastroenterology & Hepatology

Sepsis in alcohol-related liver disease

Thierry Gustot et al.

JOURNAL OF HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Binge drinking and the risk of liver events: A population-based cohort study

Fredrik Aberg et al.

LIVER INTERNATIONAL (2017)

Editorial Material Gastroenterology & Hepatology

Binge drinking as a risk factor for advanced alcoholic liver disease

Meritxell Ventura-Cots et al.

LIVER INTERNATIONAL (2017)

Article Gastroenterology & Hepatology

Alcohol, smoking and the liver disease patient

Hannes Hagstrom

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)

Article Substance Abuse

Phosphatidylethanol Detects Moderate-to-Heavy Alcohol Use in Liver Transplant Recipients

Michael Francis Fleming et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2017)

Review Medicine, General & Internal

Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease

Lorenzo Leggio et al.

AMERICAN JOURNAL OF MEDICINE (2017)

Article Gastroenterology & Hepatology

Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome

L. Bucci et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Review Immunology

Liver Transplantation for Alcoholic Liver Disease

Giovanni Addolorato et al.

TRANSPLANTATION (2016)

Article Medicine, General & Internal

Prednisolone or Pentoxifylline for Alcoholic Hepatitis

Mark R. Thursz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Gastroenterology & Hepatology

Consequences of Perceived Stigma Among Patients with Cirrhosis

Valerie Vaughn-Sandler et al.

DIGESTIVE DISEASES AND SCIENCES (2014)

Article Gastroenterology & Hepatology

A Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis

Jose Altamirano et al.

GASTROENTEROLOGY (2014)

Review Substance Abuse

The Economic Burden of Alcohol Dependence in Europe

Philippe Laramee et al.

ALCOHOL AND ALCOHOLISM (2013)

Article Gastroenterology & Hepatology

Abusive Drinking After Liver Transplantation Is Associated With Allograft Loss and Advanced Allograft Fibrosis

John P. Rice et al.

LIVER TRANSPLANTATION (2013)

Article Gastroenterology & Hepatology

Acute Kidney Injury Is an Early Predictor of Mortality for Patients With Alcoholic Hepatitis

Jose Altamirano et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

Complications in Patients with Alcohol-Associated Liver Disease Who Undergo Liver Transplantation

Paul J. Gaglio et al.

CLINICS IN LIVER DISEASE (2012)

Article Gastroenterology & Hepatology

Predictive factors of abstinence in patients undergoing liver transplantation for alcoholic liver disease

Jose Altamirano et al.

ANNALS OF HEPATOLOGY (2012)

Review Gastroenterology & Hepatology

Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets

Bin Gao et al.

GASTROENTEROLOGY (2011)

Article Medicine, General & Internal

Early Liver Transplantation for Severe Alcoholic Hepatitis

Philippe Mathurin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

Glucocorticoids plus N-Acetylcysteine in Severe Alcoholic Hepatitis

Eric Nguyen-Khac et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Gastroenterology & Hepatology

Validation of prognostic scores for clinical use in patients with alcoholic hepatitis

Thomas Damgaard Sandahl et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)

Article Substance Abuse

Defining Binge Drinking as Five Drinks per Occasion or Drinking to a .08% BAC: Which Is More Sensitive to Risk?

Mark T. Fillmore et al.

AMERICAN JOURNAL ON ADDICTIONS (2011)

Article Substance Abuse

Biomarkers of Liver Status in Heavy Drinkers, Moderate Drinkers and Abstainers

Paivikki Alatalo et al.

ALCOHOL AND ALCOHOLISM (2009)

Article Medicine, General & Internal

Alcohol and Global Health 3 Reducing harm from alcohol: call to action

Sally Casswell et al.

LANCET (2009)

Review Medicine, General & Internal

MEDICAL PROGRESS Alcoholic Hepatitis

Michael R. Lucey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Gastroenterology & Hepatology

A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis

Marlene Dominguez et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis

Nicholas C. Boetticher et al.

GASTROENTEROLOGY (2008)

Review Gastroenterology & Hepatology

Mechanisms of hepatic fibrogenesis

Scott L. Friedman

GASTROENTEROLOGY (2008)

Article Medicine, General & Internal

A simple score for predicting alcohol relapse after liver transplantation - Results from 387 patients over 15 years

Andrea De Gottardi et al.

ARCHIVES OF INTERNAL MEDICINE (2007)

Article Gastroenterology & Hepatology

Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease

Robert Pfitzmann et al.

LIVER TRANSPLANTATION (2007)

Article Gastroenterology & Hepatology

Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features

Silvano Fasolato et al.

HEPATOLOGY (2007)

Article Gastroenterology & Hepatology

Tobacco use following liver transplantation for alcoholic liver disease: An underestimated problem

A DiMartini et al.

LIVER TRANSPLANTATION (2005)

Article Medicine, General & Internal

Efficacy and tolerability of long-acting injectable for alcohol dependence - A randomized controlled trial

JC Garbutt et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Article Gastroenterology & Hepatology

MELD accurately predicts mortality in patients with alcoholic hepatitis

W Dunn et al.

HEPATOLOGY (2005)

Article Substance Abuse

Hemochromatosis and alcoholic liver disease

LM Fletcher et al.

ALCOHOL (2003)

Review Medicine, General & Internal

Outpatient management of patients with alcohol problems

DA Fiellin et al.

ANNALS OF INTERNAL MEDICINE (2000)